Immix Biopharma, Inc.
IMMX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $66,727 | $62,066 | $49,898 | $60,588 |
| - Cash | $15,947 | $11,638 | $15,921 | $17,682 |
| + Debt | $1,106 | $1,043 | $1,059 | $1,075 |
| Enterprise Value | $51,886 | $51,471 | $35,036 | $43,981 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$7,481 | -$6,638 | -$4,624 | -$4,946 |
| % Margin | – | – | – | – |
| Net Income | -$7,586 | -$6,623 | -$4,543 | -$4,812 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.24 | -0.22 | -0.15 | -0.17 |
| % Growth | -9.1% | -46.7% | 11.8% | – |
| Operating Cash Flow | -$5,906 | -$5,310 | -$1,685 | -$1,476 |
| Capital Expenditures | -$372 | -$128 | -$68 | -$507 |
| Free Cash Flow | -$6,278 | -$5,437 | -$1,753 | -$1,983 |